BLCM   $0.6497  -6.95% Market Closed

Bellicum Pharmaceuticals Inc
Total Cash 5.91M
totalCashPerShare 0.608
EBITDA -23.82M
Total Debt 0.00
quickRatio 2.634
currentRatio 3.045
Total Revenue 1.51M
debtToEquity
Revenue/Share 0.049
ROA -0.78096
ROE -1.4849899
grossProfits
freeCashflow -15.37M
operatingCashflow -22.85M
earningsGrowth
revenueGrowth 0.0
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -0.774
profitMargins 0.0
enterpriseValue 26.44M
forwardPE
floatShares 6.78M
sharesOutstanding 9.72M
sharesShort 1.44M
sharesShortPriorMonth 91.00K
dateShortInterest
sharesPercentSharesOut 0.15%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.33%
Short Ratio help_outline 0.17%
shortPercentOfFloat 0.17%
impliedSharesOutstanding
bookValue -2.78
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -22.38M
trailingEps -0.67%
forwardEps -0.96%
enterpriseToEbitda -1.11
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2023
institutionsCount 5
lastUpdated April 16, 2024, 7:57 p.m.